Michal Novotny

Michal Novotny

Auto-generated profile, based on publicly available information

Michal Novotny

Czech Technical University in Prague

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 June 2014 in IEEE/ACM Transactions on Audio, Speech, and Language Processing
Verified
Journal Article
Closed access
MNMichal Novotny
Michal Novotny
JRJan Rusz
Jan Rusz
RCRoman Cmejla
Roman Cmejla
EREvžen Růžička
Evžen Růžička
Although articulatory deficits represent an important manifestation of dysarthria in Parkinson’s disease (PD), the most widely used methods currently available for the automatic evaluation of speech performance are focused on the assessment of dysphonia. The aim of the present study was to design a reliable automatic approach for the precise estimation of articulatory deficits in PD. Twenty-four individuals diagnosed with de novo PD and twenty-two age-matched healthy controls were recruited. Each participant performed diadochokinetic tasks based upon the fast repetition of /pa/-/ta/-/ka/ syllables. All phonemes were manually labeled and an algorithm for their automatic detection was designed. Subsequently, 13 features describing six different articulatory aspects of speech including vowel quality, coordination of laryngeal and supralaryngeal activity, precision of consonant articulation, tongue movement, occlusion weakening, and speech timing were analyzed. In addition, a classification experiment using a support vector machine based on articulatory features was proposed to differentiate between PD patients and healthy controls. The proposed detection algorithm reached approximately 80% accuracy for a 5 ms threshold of absolute difference between manually labeled references and automatically detected positions. When compared to controls, PD patients showed impaired articulatory performance in all investigated speech dimensions ( $p < 0.05$ ). Moreover, using the six features representing different aspects of articulation, the best overall classification result attained a success rate of 88% in separating PD from controls. Imprecise consonant articulation was found to be the most powerful indicator of PD-related dysarthria. We envisage our approach as the first step towards development of acoustic methods allowing the automated assessment of articulatory features in dysarthrias.

17 February 2015 in Journal of Neurology
Verified
Journal Article
Closed access
PDF file
JRJan Rusz
Jan Rusz
CBCecilia Bonnet
Cecilia Bonnet
JKJiri Klempir
Jiri Klempir
TTTereza Tykalová
Tereza Tykalová
EBEva Baborová
Eva Baborová
EREvžen Růžička
Evžen Růžička

29 June 2018 in IEEE Transactions on Neural Systems and Rehabilitation Engineering
Verified
Journal Article
Closed access
JRJan Rusz
Jan Rusz
JHJan Hlavnicka
Jan Hlavnicka
TTTereza Tykalova
Tereza Tykalova
MNMichal Novotny
Michal Novotny
PDPetr Dusek
Petr Dusek
EREvzen Ruzicka
Evzen Ruzicka
Although smartphone technology provides new opportunities for the recording of speech samples in everyday life, its ability to capture prodromal speech impairment in persons with a high risk of developing Parkinson's disease (PD) has never been investigated. Speech data were acquired through a smartphone as well as a professional microphone with a linear frequency response from 50 participants with a rapid eye movement sleep behavior disorder that are at a high risk of developing PD and related neurodegenerative disorders. Additionally, recordings of 30 newly diagnosed, untreated PD patients and 30 healthy participants were evaluated. Acoustic assessment of 11 speech dimensions representing the key aspects of hypokinetic dysarthria in the early stages of PD was performed. Smartphone allowed the detection of speech abnormalities in participants with a high risk of developing PD. Acoustic measurements related to fundamental frequency variability, duration of pause intervals, and rate of speech timing extracted from spontaneous speech were sufficiently sensitive to significantly separate groups (area under curve of 0.85 between PD and controls) and showed very strong correlation and reliability between the professional microphone and the smartphone. Speech-based biomarkers collected through smartphones may have the potential to revolutionize the diagnostic process in neurodegenerative diseases and improve stratification for future neuroprotective therapy in PD.

1 January 2018 in Multiple Sclerosis and Related Disorders
Verified
Journal Article
Closed access
JRJan Rusz
Jan Rusz
BBBarbora Benova
Barbora Benova
HRHana Ruzickova
Hana Ruzickova
MNMichal Novotny
Michal Novotny
TTTereza Tykalova
Tereza Tykalova
DHDana Horakova
Dana Horakova

23 November 2021 in Neurology
Verified
Journal Article
Closed access
PDF file
JRJan Rusz
Jan Rusz
TTTereza Tykalova
Tereza Tykalova
MNMichal Novotny
Michal Novotny
DZDavid Zogala
David Zogala
KSKarel Sonka
Karel Sonka
PDPetr Dusek
Petr Dusek
Background and Objectives: Patterns of speech disorder in Parkinson9s disease (PD), that are highly variable across individual patients, were not systematically studied. Our aim was to identify speech subtypes in treatment-naïve PD patients and examine their response to long-term dopaminergic therapy. Methods: We recorded speech data from a total of 111 de-novo PD participants; 83 of the participants completed the 12-month follow-up (69 PD subjects on stable dopaminergic medication and 14 untreated PD controls). Unsupervised k-means cluster analysis was performed on eight distinctive parameters of hypokinetic dysarthria examined using quantitative acoustic analysis. Results: Three distinct speech subtypes with similar prevalence, symptom duration and motor severity were detected: 9prosodic9, 9phonatory-prosodic9 and 9articulatory-prosodic9. Beside monopitch and monoloudness that were common in each subtype, speech impairment was more severe in phonatory-prosodic subtype with predominant dysphonia and articulatory-prosodic subtype with predominant imprecise consonant articulation than in prosodic subtype. Clinically, the prosodic subtype was characterized by a prevalence of women and younger age while articulatory-prosodic subtype by the prevalence of men, older age, greater severity of axial gait symptoms and poorer cognitive performance. Phonatory-prosodic subtype clinically represented intermediate status in age with mostly men and preserved cognitive performance. While speech of untreated PD controls deteriorated over one year (p = 0.02), long-term dopaminergic medication maintained stable speech impairment severity in prosodic and articulatory-prosodic subtypes and improved speech performance in patients with phonatory-prosodic subtype (p = 0.002). Discussion: Distinct speech phenotypes in de-novo PD reflect divergent underlying mechanisms and allow to predict response of speech impairment to levodopa therapy. Classification of Evidence: This study provides Class II evidence that, in patients with newly diagnosed PD with speech impairment, speech phenotype is associated with levodopa responsiveness.

11 November 2021 in npj Parkinson's Disease
Verified
Journal Article
Open access
PDF file
JRJan Rusz
Jan Rusz
TTTereza Tykalová
Tereza Tykalová
MNMichal Novotný
Michal Novotný
EREvžen Růžička
Evžen Růžička
PDPetr Dušek
Petr Dušek
Substantial variability and severity of dysarthric patterns across Parkinson’s disease (PD) patients may reflect distinct phenotypic differences. We aimed to compare patterns of speech disorder in early-onset PD (EOPD) and late-onset PD (LOPD) in drug-naive patients at early stages of disease. Speech samples were acquired from a total of 96 participants, including two subgroups of 24 de-novo PD patients and two subgroups of 24 age- and sex-matched young and old healthy controls. The EOPD group included patients with age at onset below 51 (mean 42.6, standard deviation 6.1) years and LOPD group patients with age at onset above 69 (mean 73.9, standard deviation 3.0) years. Quantitative acoustic vocal assessment of 10 unique speech dimensions related to respiration, phonation, articulation, prosody, and speech timing was performed. Despite similar perceptual dysarthria severity in both PD subgroups, EOPD showed weaker inspirations (p = 0.03), while LOPD was characterized by decreased voice quality (p = 0.02) and imprecise consonant articulation (p = 0.03). In addition, age-independent occurrence of monopitch (p < 0.001), monoloudness (p = 0.008), and articulatory decay (p = 0.04) was observed in both PD subgroups. The worsening of consonant articulation was correlated with the severity of axial gait symptoms (r = 0.38, p = 0.008). Speech abnormalities in EOPD and LOPD share common features but also show phenotype-specific characteristics, likely reflecting the influence of aging on the process of neurodegeneration. The distinct pattern of imprecise consonant articulation can be interpreted as an axial motor symptom of PD.